Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In an 8-week study using low-dose liraglutide (0.6 mg/day) in patients with type 2 diabetes no weight or fat loss was produced, but both fasting and postprandial glucose were substantially reduced, but neither fasting nor postprandial insulin (or C-peptide) response was increased [19]
Cell and Tissue Research, 372 (1), 9198
(11) T J Smith (2010) Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases
These are peptide drugs needing specialized, capital-intensive production, which raises costs and limits how fast supply can scale
The evidence speaks volumes
US$ 21.51
US$ 23.70
US$ 29.65
US$ 28.99
US$ 29.51
US$ 25.14
US$ 21.52
US$ 24.20
